Assay Detail

CHEMBL1769103

Review assay metadata, readout intent, target linkage, and publication context from the same page.

Binding

Inhibition of LCK

ChEMBL ↗

Free Research Context This assay will appear in recent viewed items on this browser. Open the demo workspace to preview project-only review queues.

Research home Demo workspace

Target

Tyrosine-protein kinase Lck (CHEMBL258) ↗

Open DB target context

Use one target anchor to keep assay intent, target linkage, and tested compound review aligned.

Loading context

Tyrosine-protein kinase Lck (CHEMBL258) is the working anchor for this assay review. Loading the live Open DB target snapshot…

Primary target Tyrosine-protein kinase Lck

CHEMBL258

Anchored from Assay target.

Protein identity Tyrosine-protein kinase Lck

Disease frame Disease evidence pending

Open the live target snapshot or evidence card before reviewing assay metadata so target fit and disease framing stay reusable.

Review focus Open DB context pending

Open the live target snapshot before relying on this target frame across surface handoff.

Open target snapshot Open evidence card Search with this context

Total Activities

Compounds Tested

Activity Types

Assay Parameters

Assay Information

Assay Type	Binding
Confidence	8 — Homologous single protein target
Curated By	Autocuration

Target

Tyrosine-protein kinase Lck (CHEMBL258) ↗

Type	SINGLE PROTEIN
Organism	Homo sapiens

Publication

Discovery of 6-(2,4-difluorophenoxy)-2-[3-hydroxy-1-(2-hydroxyethyl)propylamino]-8-methyl-8H-pyrido[2,3-d]pyrimidin-7-one (pamapimod) and 6-(2,4-difluorophenoxy)-8-methyl-2-(tetrahydro-2H-pyran-4-ylamino)pyrido[2,3-d]pyrimidin-7(8H)-one (R1487) as orally bioavailable and highly selective inhibitors of p38α mitogen-activated protein kinase.

Goldstein DM, Soth M, Gabriel T, Dewdney N, Kuglstatter A, Arzeno H, Chen J, Bingenheimer W, Dalrymple SA, Dunn J, Farrell R, Frauchiger S, La Fargue J, Ghate M, Graves B, Hill RJ, Li F, Litman R, Loe B, McIntosh J, McWeeney D, Papp E, Park J, Reese HF, Roberts RT, Rotstein D, San Pablo B, Sarma K, Stahl M, Sung ML, Suttman RT, Sjogren EB, Tan Y, Trejo A, Welch M, Weller P, Wong BR, Zecic H.
J Med Chem (2011) 54 : 2255 -2265
PubMed 21375264 · DOI

Activity Statistics

Type	Count	Avg pChEMBL	Best pChEMBL
Kd	3	7.73	9.70

Compounds Tested

Compound	Name	Phase	Activities	Best pChEMBL
CHEMBL1234002	—	—	1	9.70
CHEMBL1766490	—	—	1	5.75
CHEMBL1235713	—	—	1	-

Activity Data

Compound	Name	Type	Rel.	Value	Units	pChEMBL
CHEMBL1234002	—	Kd	=	0.2	nM	9.70
CHEMBL1766490	—	Kd	=	1800.0	nM	5.75
CHEMBL1235713	—	Kd	>	20000.0	nM	-